Literature DB >> 15739096

Endothelial functions in Behçet's disease.

Meral Kayikçioğlu1, Kenan Aksu, Can Hasdemir, Gokhan Keser, Nevbahar Turgan, Hakan Kültürsay, Eker Doganavsargil.   

Abstract

Behçet's disease (BD) is a systemic vasculitis, capable of involving all types of vessels. Endothelial dysfunction (ED) has been previously documented in BD. The aim of the study was to see whether ED was more prominent in Behçet's patients with vascular involvement (VI) than in those without. The study population consisted of 65 patients with BD, 27 of whom had VI, and 30 healthy controls. High-resolution ultrasound was used to measure endothelium-dependent vasodilatation (EDVD) of brachial artery. Overall, regardless of VI, EDVD was significantly impaired in patients with BD compared with controls (11.4 +/- 6.3 vs 20.4 +/- 9.1%,P = 0.001); however, EDVD was similar in BD patients with and without VI (9.7 +/- 6.3% vs 12.6 +/- 6.1%, P = 0.07). Patients with BD had significantly-higher plasma homocysteine levels than controls (13 +/- 6 micromol/L vs 9 +/- 3 micromol/L, P = 0.001). Plasma homocysteine levels were significantly higher in the subgroup with VI than in those without (15 +/- 7 micromol/L vs 12 +/- 4 micromol/L, P = 0.03); however, we found no positive/significant correlation between plasma homocysteine levels and EDVD. ED is a constant feature of BD, regardless of VI. Etiology of ED in BD is probably multifactorial, including high homocysteine levels. As both ED and elevated homocysteine levels may represent an early atherosclerotic process, a more structured approach to risk factor assessment is needed in BD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15739096     DOI: 10.1007/s00296-005-0590-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Serum homocysteine level in Behçet's disease.

Authors:  Emel Calikoğlu; Murat Oztaş; Neriman Sengül; Bahattin Adam; Mehmet Ali Gürer
Journal:  Haematologia (Budap)       Date:  2002

2.  A case of Behçet's disease with pulmonary arterial aneurysm and secondary amyloidosis.

Authors:  K Aksu; H Koçanaoğullari; G Keser; V Inal; Y Kabasakal; F Oksel; G Gümüşdiş; E Doğanavşargil
Journal:  Rheumatology (Oxford)       Date:  2002-07       Impact factor: 7.580

3.  Vascular endothelial function and plasma homocysteine levels in Behcet's disease.

Authors:  Ramazan Ozdemir; Irfan Barutcu; Alpay T Sezgin; Nusret Acikgoz; Necip Ermis; Ali Metin Esen; Ergun Topal; Emrah Bariskaner; Ibrahim Ozerol
Journal:  Am J Cardiol       Date:  2004-08-15       Impact factor: 2.778

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  Silent myocardial ischemia in Behçet's disease.

Authors:  I H Güllü; M Benekli; H Müderrisoğlu; A Oto; E Kansu; G Kabakçi; E Oram; C Bekdik
Journal:  J Rheumatol       Date:  1996-02       Impact factor: 4.666

6.  Evidence for an endothelial cell dysfunction in association with Behçet's disease.

Authors:  U Schmitz-Huebner; J Knop
Journal:  Thromb Res       Date:  1984-05-15       Impact factor: 3.944

7.  Hyperhomocysteinaemia in Behçet's disease.

Authors:  K Aksu; N Turgan; F Oksel; G Keser; D Ozmen; G Kitapçioğlu; G Gümüşdiş; O Bayindir; E Doğanavşargil
Journal:  Rheumatology (Oxford)       Date:  2001-06       Impact factor: 7.580

Review 8.  Methods for homocysteine analysis and biological relevance of the results.

Authors:  Véronique Ducros; Karine Demuth; Marie-Pierre Sauvant; Muriel Quillard; Elisabeth Caussé; Mirande Candito; Marie-Hélène Read; Jocelyne Drai; Isabelle Garcia; Marie-Françoise Gerhardt
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-12-05       Impact factor: 3.205

9.  Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?

Authors:  K Raza; J Thambyrajah; J N Townend; A R Exley; C Hortas; A Filer; D M Carruthers; P A Bacon
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

10.  Oxidative stress in Adamantiades-Behçet's disease.

Authors:  J P Freitas; P Filipe; A Yousefi; I Emerit; F Guerra Rodrigo
Journal:  Dermatology       Date:  1998       Impact factor: 5.366

View more
  11 in total

1.  Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.

Authors:  Murat Yuksel; Abdulkadir Yildiz; Mustafa Oylumlu; Fatih Mehmet Turkcu; Mehmet Zihni Bilik; Aysun Ekinci; Bilal Elbey; Ebru Tekbas; Sait Alan
Journal:  Clin Rheumatol       Date:  2015-03-07       Impact factor: 2.980

2.  Intima-media thickness and arterial stiffness of carotid artery in Korean patients with Behçet's disease.

Authors:  Moo-Yong Rhee; Hyun Kyu Chang; Seong-Kyu Kim
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

3.  Assessment of serum homocysteine, endothelin-1, and nitric oxide levels in behçet's disease.

Authors:  Abeer A Hodeib; Tarek A Elsharawy; Hisham A Fawzi
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

4.  Serum prolidase enzyme activity and oxidative status in patients with Behçet's disease.

Authors:  Mehtap Bozkurt; Hatice Yüksel; Serda Em; Pelin Oktayoglu; Mehmet Yildiz; Dicle Akdeniz; Kemal Nas
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

5.  Increased endothelin-1 levels of BAL fluid in patients with Behçet's disease.

Authors:  Kamel Hamzaoui; Hanene Chelbi; Mariam Kamoun; Imen Ben Dhifallah; Agnes Hamzaoui
Journal:  Mediators Inflamm       Date:  2007-03-19       Impact factor: 4.711

6.  Behçet's disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes.

Authors:  Sergio Burillo-Sanz; Marco-Antonio Montes-Cano; José-Raúl García-Lozano; Israel Olivas-Martínez; Norberto Ortego-Centeno; Francisco-José García-Hernández; Gerard Espinosa; Genaro Graña-Gil; Juan Sánchez-Bursón; María Rosa Juliá; Roser Solans; Ricardo Blanco; Ana-Celia Barnosi-Marín; Ricardo Gómez de la Torre; Patricia Fanlo; Mónica Rodríguez-Carballeira; Luis Rodríguez-Rodríguez; Teresa Camps; Santos Castañeda; Juan-Jose Alegre-Sancho; Javier Martín; María Francisca González-Escribano
Journal:  Sci Rep       Date:  2019-02-26       Impact factor: 4.379

7.  The risk of endothelial and erectile dysfunctions in Behçet's disease: a comparative analysis of mucocutaneous and systemic patient groups.

Authors:  Yasemin Erdem; Selcuk Erdem; Mehmet Barburoglu; Ekrem Bilal Karaayvaz; Erkingul Shugaiv; Murat Kurtuncu; Artur Salmaslioglu; Huseyin Oflaz; Afet Akdag Kose; Ates Kadioglu
Journal:  Postepy Dermatol Alergol       Date:  2021-09-17       Impact factor: 1.837

8.  Interrelated modulation of endothelial function in Behcet's disease by clinical activity and corticosteroid treatment.

Authors:  Athanase D Protogerou; Petros P Sfikakis; Kimon S Stamatelopoulos; Christos Papamichael; Kostas Aznaouridis; Emmanuil Karatzis; Theodore G Papaioannou; Ignatios Ikonomidis; Phedon Kaklamanis; Myron Mavrikakis; John Lekakis
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Increased Arterial Stiffness in Behçet's Disease: a Systematic Review and Meta-Analysis.

Authors:  Sikarin Upala; Wai Chung Yong; Anawin Sanguankeo
Journal:  Korean Circ J       Date:  2017-07-27       Impact factor: 3.243

10.  Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case-control frequency-matched study.

Authors:  Lei Qin; Yi-Wei Kao; Yueh-Lung Lin; Bou-Yue Peng; Win-Ping Deng; Tsung-Ming Chen; Kuan-Chou Lin; Kevin Sheng-Po Yuan; Alexander T H Wu; Ben-Chang Shia; Szu-Yuan Wu
Journal:  Cancer Med       Date:  2018-07-15       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.